Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Mar 8.

Published in final edited form as: Biomacromolecules. 2010 Mar 8;11(3):754–761. doi: 10.1021/bm901352v

Biodistribution profiles (n = 3) of the gadolinium content in the major organs and tissues for G2, G3 and peptide targeted G2 (P-G2), G3 (P-G3) nanoglobular MRI contrast agents at 48 h after administration. (* P < 0.05)

Biodistribution profiles (n = 3) of the gadolinium content in the major organs and tissues for G2, G3 and peptide targeted G2 (P-G2), G3 (P-G3) nanoglobular MRI contrast agents at 48 h after administration. (* P < 0.05)